John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 320,288 shares at $100.45 ($31.9M) on 2018-03-07, disclosed to the SEC on 2018-03-08.
Open-market sale of $31.9M NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.29 | 120,000 | $11.8M | 37.0% |
| 2 | $100.45 | 100,144 | $10.1M | 31.5% |
| 3 | $100.45 | 100,144 | $10.1M | 31.5% |
| Total | $99.64 avg | 320,288 | $31.9M | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |